Functional impairment of dendritic cells caused by murine hepatocellular carcinoma

scientific article published on March 2004

Functional impairment of dendritic cells caused by murine hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1017756295
P356DOI10.1023/B:JOCI.0000019779.56180.A2
P698PubMed publication ID15024181

P2093author name stringWei-Chen Lee
Miin-Fu Chen
Hui-Chuan Wang
Min-Ru Wang
Shin-Ru Lia
Yang-Jen Chiang
P2860cites workRapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysQ25939005
Dendritic cells and the control of immunityQ27860918
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliabilityQ29617252
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factorQ29619247
The Fas counterattack: cancer as a site of immune privilegeQ33542332
Impediments to successful immunotherapyQ33586651
Effects of TGF-beta on the immune system: implications for cancer immunotherapy.Q33713481
Interleukin-10: a cytokine used by tumors to escape immunosurveillanceQ33717191
Signaling defects in T lymphocytes of patients with malignancyQ33740933
The role for transforming growth factor-beta (TGF-beta) in human cancerQ33828205
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytesQ34396514
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expressionQ34504988
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipientsQ35160185
The role of surface HLA-A,B,C molecules in tumour immunityQ35475241
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligandQ36367323
Altered immune responses in interleukin 10 transgenic miceQ36377330
Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanomaQ36763316
Origin, maturation and antigen presenting function of dendritic cells.Q40906220
Increased interleukin-10 serum levels in patients with solid tumours.Q40936263
Dendritic cells presenting tumor antigen.Q41320950
Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes backQ41465258
Reversal of tumor-induced immunosuppression: a new approach to cancer therapyQ41496259
T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.Q41697252
Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells.Q52999151
In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.Q53462875
Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer.Q53803561
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysisQ57080563
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsQ71607047
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of toleranceQ72230111
The natural history of hepatocellular carcinoma. A study of 100 untreated casesQ72742215
Induction of tolerance by IL-10-treated dendritic cellsQ73873437
Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patientsQ74079403
P433issue2
P304page(s)145-154
P577publication date2004-03-01
P1433published inJournal of Clinical ImmunologyQ6294961
P1476titleFunctional impairment of dendritic cells caused by murine hepatocellular carcinoma
P478volume24

Reverse relations

cites work (P2860)
Q36040825Antisense therapy for restenosis following percutaneous coronary intervention.
Q37829504Immunotherapeutic modulation of the suppressive liver and tumor microenvironments
Q51536303Serum cytokine levels in chronic hepatitis B patients receiving peginterferon alpha-2a therapy.
Q51544498Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy.
Q79445998Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton

Search more.